Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
Frontiers in Public Health|August 29, 2022
Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in ChinaYinan Ren, Mingye Zhao, Dachuang Zhou, et al.BMC Public Health|January 21, 2025
Comparing the cost-benefit of breast cancer screening programs in rural and urban areas across four economic zones in China: a Markov modeling analysisDachuang Zhou, Kejia Zhou, Wenjuan Wang, et al.Cost Effectiveness and Resource Allocation : C/E|September 18, 2024
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspectiveHanqiao Shao, Hongshu Fang, Yuan Li, et al.Journal of the American Academy of Dermatology|April 11, 2017
Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014Michael Migden, Jipan Xie, Jin Wei, et al.Frontiers in Public Health|May 2, 2022
Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-AnalysisMingye Zhao, Xingming Pan, Yue Yin, et al.Journal of Medical Economics|June 1, 2017
The effects of global budget on cost control and readmission in rural China: a difference-in-difference analysisRuibo He, Yudong Miao, Ting Ye, et al.Environment International|January 29, 2025
Air pollution-related disease and economic burden in China, 1990-2050: A modelling study based on Global burden of diseaseDachuang Zhou, Yang Yang, Zhenping Zhao, et al.BMC Anesthesiology|July 14, 2017
Case report: perioperative management of caesarean section for a parturient with mitochondrial myopathyQiang Zheng, Penghui Wei, Jinfeng Zhou, et al.Infectious Agents and Cancer|April 18, 2025
Cost-benefit analysis of p16<sup>INK4a</sup> immunocytology and liquid-based cytology triage after primary HPV testing for cervical cancer screening in ChinaDachuang Zhou, Jun Hou, Jiayi Xi, et al.Journal of Translational Internal Medicine|December 13, 2021
The Lifetime Cost Estimation of Human Papillomavirus-related Diseases in China: A Modeling StudyWenpei Ding, Yue Ma, Chao Ma, et al.Pageof 11